Development and validation of a reversed-phase HPLC method for quantification of 1’-acetoxychavicol acetate content in a nanostructured lipid carrier formulation

Eitemau Tebyg

• Development and Evaluation of 1′-Acetoxychavicol Acetate (ACA)-Loaded Nanostructured Lipid Carriers for Prostate Cancer Therapy
  gan: Bavani Subramaniam, et al.
  Cyhoeddwyd: (2021-03-01)
• The Apoptotic Effect of 1’S-1’-Acetoxychavicol Acetate from Alpinia Conchigera on Human Cancer Cells
  gan: Noor Hasima Nagoor, et al.
  Cyhoeddwyd: (2010-11-01)
• In Vitro Activities of Enantiopure and Racemic 1′-Acetoxychavicol Acetate against Clinical Isolates of Mycobacterium tuberculosis
  gan: Saradee Warit, et al.
  Cyhoeddwyd: (2017-09-01)
• Screening and identification of potential target of 1′-acetoxychavicol acetate (ACA) in acquired lapatinib-resistant breast cancer
  gan: Febri Wulandari, et al.
  Cyhoeddwyd: (2024-12-01)
• 1’-Acetoxychavicol acetate inhibits growth of human oral carcinoma xenograft in mice and potentiates cisplatin effect via proinflammatory microenvironment alterations
  gan: In Lionel LA, et al.
  Cyhoeddwyd: (2012-10-01)